News
President John Mahama has announced the Ghana Medical Care Trust Fund (MahamaCares) initiative as more than just a healthcare ...
INVO Fertility, Inc. (Nasdaq: NAYA), formerly known as NAYA Biosciences, Inc., a healthcare services fertility company focused on expanding access to ...
Dehradun: Uttarakhand waqf board and Muslim social organisations have claimed that the mazaar demolished at Government Doon ...
Gladys arrived at the Cincinnati Zoo in 2013 after her mom at the Gladys Porter Zoo decided not to care for her, creating the ...
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development ...
Prime Medicine’s modular editing tech may lower off-target risk, but key data and funding milestones remain ahead. Find out ...
The accused, a middle-aged Chinese man dressed in a pale blue shirt and jeans, sat quietly on the bench in the defendant’s ...
Raqab, 4, lies emaciated at 20 pounds in hospital, embodying catastrophic health, humanitarian toll of blockade - Anadolu ...
The recent update to ISO 15223-1, formalized through Amendment 1:2025, ushers in a critical shift for medical device labeling ...
The Quebec minister responsible for secularism says the government isn’t ruling out expanding its religious symbols ban to ...
The trial in Yale School of Medicine's Department of Psychiatry will be led by Dr. Anahita Bassir Nia, M.D., a specialist in substance abuse, including alcohol abuse. The trial will also be conducted ...
CMND-100 is Clearmind’s proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results